NUVB · ISSUER CIK 1811063
Nuvation Bio Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 Nuvation Bio Inc. insiders reported $0.00 of open-market purchases and $709K of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 1 of 1 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$709KInsider selling
−$709KNet open-market
Aug 21, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 21, 202616:49 | Aug 19, 2026 | NUVB | CHIEF SCIENTIFIC OFFICER | S · Sell10b5-1 | $7.09 | −100,000 | 0 | -100% | −$709K | ||
| Aug 21, 202616:49 | Aug 19, 2026 | NUVB | CHIEF SCIENTIFIC OFFICER | M · Exercise10b5-1 | $1.87 | +100,000 | 100,000 | New | $187K |